Uric Acid Lowering Trial in Youth Onset T2D

NCT03899883 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Kidney Disease
Hyperuricemia
Diabetes
Diabetes Mellitus, Type 2
Type2 Diabetes
Type 2 Diabetes Mellitus
Diabetic Nephropathies
Diabetes Complications

Interventions

DRUG: Pegloticase 8 MG/ML [Krystexxa]

Sponsor

University of Colorado, Denver